Sage Journals: Discover world-class research

Abstract

Recent extensive evidence suggests that ambient fine particulate matter (PM2.5, with an aerodynamic diameter ≤2.5 μm) may be neurotoxic to the brain and cause central nervous system damage, contributing to neurodevelopmental disorders, such as autism spectrum disorders, neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and mental disorders, such as schizophrenia, depression, and bipolar disorder. PM2.5 can enter the brain via various pathways, including the blood–brain barrier, olfactory system, and gut-brain axis, leading to adverse effects on the CNS. Studies in humans and animals have revealed that PM2.5-mediated mechanisms, including neuroinflammation, oxidative stress, systemic inflammation, and gut flora dysbiosis, play a crucial role in CNS damage. Additionally, PM2.5 exposure can induce epigenetic alterations, such as hypomethylation of DNA, which may contribute to the pathogenesis of some CNS damage. Through literature analysis, we suggest that promising therapeutic targets for alleviating PM2.5-induced neurological damage include inhibiting microglia overactivation, regulating gut microbiota with antibiotics, and targeting signaling pathways, such as PKA/CREB/BDNF and WNT/β-catenin. Additionally, several studies have observed an association between PM2.5 exposure and epigenetic changes in neuropsychiatric disorders. This review summarizes and discusses the association between PM2.5 exposure and CNS damage, including the possible mechanisms by which PM2.5 causes neurotoxicity.

Keywords

PM2.5 autism neurodegenerative diseases mental disorders

Introduction

The problem of air pollution has become a worldwide concern as industrialization has progressed. PM2.5 is one of the most complex and harmful air pollutants, degrading environmental quality and posing a significant risk to human health. Long-term exposure to PM2.5 increases respiratory disease, lung cancer, and cardiovascular disease mortality.^1,2 It also exerts pathological effects on the central nervous system (CNS), with the brain as the primary target.

The PM2.5 sources are complex and diverse, including outdoor and indoor sources. Outdoor PM2.5 is primarily derived from heating fuels, industry, and traffic. However, indoor PM2.5 originates from fuel combustion, human activities, equipment operation, cleaning, and cooking.³ The PM2.5 composition is also determined by its sources, with various chemical components, such as salts of sulfate (and nitrate) and carbons, contributing to its complex composition. PM2.5 can easily adsorb toxic and harmful substances, including polycyclic aromatic hydrocarbons (PAHs), heavy metals, and microorganisms, due to its small particle size, large surface area, and high activity. Carbon components, such as elementary carbon (EC) and organic carbon (OC), have been identified as the primary sources of toxicity for PM2.5, based on various studies.^4,5

Recent studies have detected air pollution particles in the placenta, blood, and fetal tissue samples of mothers exposed to air pollution and in human cerebrospinal fluids (CSFs).^6,7 The first pathway is blood circulation, where PM2.5 enters the lungs via the respiratory tract, travels via the blood circulation system, and eventually crosses the blood–brain barrier (BBB) to reach the brain.^7,8 The second pathway is the olfactory system, where PM2.5 enters the body via the nasal cavity and is transmitted via olfactory neurons to the olfactory bulb, then to the brain via the olfactory cortex.^9,10 The third pathway is the gut-brain axis (GBA), where PM2.5 can enter the gastrointestinal tract directly or indirectly, changing the microbiota and intestinal barrier. These changes may lead to abnormalities in the hypothalamus-pituitary-adrenal (HPA) axis and tryptophan metabolism, activating the GBA to affect brain function.^11,12

Inflammatory responses and oxidative stress have been proposed as the two primary mechanisms by which PM2.5 damages the CNS, leading to brain toxicity.^13,14 Moreover, epigenetic alterations have recently been suggested as one of the major mechanisms of PM2.5-induced brain damage.¹⁵ Numerous epidemiological investigations and animal experiments suggest that PM2.5 may be causally related to neurological or neuropsychiatric disorders, particularly neurodevelopmental disorders, neurodegenerative diseases, and mental illnesses. These diseases, whose causes are unknown and have poor treatment options, significantly diminish the quality of life and pose a substantial challenge to humanity. Therefore, it is crucial to study the potential effects of PM2.5 on the CNS. In this review, we discuss the role of PM2.5 in related CNS disorders, along with the possible underlying mechanisms. Figure 1 illustrates the impact of PM2.5 exposure on the CNS and its potential mechanisms of action.

Figure 1.

The impact of PM2.5 exposure on the CNS and its potential mechanisms of action. PM2.5 is a major pollutant that can affect the CNS through various pathways, such as the blood circulation, olfactory system, and gut-brain axis. Once PM2.5 enters the brain, it triggers neurotoxicity through two primary mechanisms: neuroinflammation and oxidative stress. Additionally, CNS damage can be exacerbated by systemic inflammation, dysbiosis of the gut microbiome, and epigenetic alterations. The adverse effects of PM2.5 on the CNS include neurodevelopmental disorders such as autism spectrum disorders, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s, as well as psychiatric disorders such as schizophrenia, depression, and bipolar disorder. Figure created using BioRender.com images.

We indexed relevant reviews and research articles from PubMed database with the following search terms: “PM2.5”, “Neurodevelopmental disorders”, “Autism spectrum disorder”, “Neurodegenerative disorders”, “Alzheimer’s disease”, “ Parkinson’s disease ”, “Mental illness”, “Schizophrenia”, “Depression”, “Bipolar disorders”, and “Air pollution”. A total of 410 articles on PM2.5 and related neurodegenerative and psychiatric diseases published between 2016 and 2023 were selected for reading. The eligible studies were selected by reading literature abstracts, and 196 literatures were finally included.

PM2.5 and neurodevelopmental disorders (NDDs)

NDDs, including autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), affect brain development and function.¹⁶ Gestation and the early postnatal period are crucial for brain development and are vulnerable to environmental toxins. Studies have reported that particulate matter exposure during pregnancy can be transmitted to the fetus via uterine and placental functional changes, resulting in detrimental effects on neurodevelopment.⁶ Our research group has established an animal model of tracheal drip PM2.5 in pregnant mice and focused on the adverse effects of PM2.5 on the development of offspring, as well as relevant intervention measures.¹⁷ Recent epidemiological studies have revealed an association between PM2.5 exposure and ADHD development.^18,19 However, relevant in vivo investigations for the underlying mechanisms are lacking. Epidemiological and animal studies involving populations from diverse geographic regions suggest that PM2.5 may be associated with ASD logy. Therefore, the following section focuses on the neurodevelopmental toxicity of PM2.5 and its possible contribution to ASD.

Association between PM2.5 and the risk of ASD

ASD begins in infancy and includes autism and various similar disorders. It is characterized by deficits in social interaction, communication difficulties, limitations in interests or activities, and stereotyped and repetitive behavior patterns. The ASD incidence has increased recently, and its development may be linked to genetic and environmental factors, although the mechanism of action is still unclear.²⁰ Several epidemiological studies have demonstrated that exposure to PM2.5 increases the risk of ASD.

Several studies have suggested prenatal exposure to PM2.5 is associated with ASD.^21–23 However, in a national case-control study of Danish children, reported that exposure to atmospheric pollutants during early infancy, rather than during pregnancy, increases the risk of a child being diagnosed with autism by monitoring and assessing atmospheric pollutant levels in maternal exposure across multiple periods from preconception to infancy.²⁴ A recent multi-point survey of case-control studies reported a positive association between ASD and PM2.5 exposure in the first year of life (OR = 1.3 [95% CI: 1.0, 1.6] per 1.6 μg/m³ increase in PM2.5).²⁵ Additionally, a study in Shanghai, China, discovered that PM2.5 exposure (the median levels = 66.2 μg/m³) significantly increased the risk of developing ASD during the first 3 years of life.²⁶ A meta-analysis also suggests that PM2.5 exposure during pregnancy is associated with an increased risk of ASD in newborns, and postnatal exposure to PM2.5 is also a risk period for the disease.²⁷ However, several studies have limitations due to multiple confounding factors, such as social class, urban residence, maternal age, and season of conception or birth. For instance, a Canadian population-based birth cohort study discovered no significant association between PM2.5 and ASD.²⁸ Therefore, the relevance of PM2.5 exposure to ASD and the possible time window of sensitivity remains controversial and requires further exploration.

Mechanisms associated with PM2.5-induced ASD

Oxidative stress and neuroinflammation

Although the mechanisms underlying the neurodevelopmental toxicity of PM2.5 have not been fully elucidated, oxidative stress is currently the most researched issue. Animal models have demonstrated that exposure to specific doses of PM2.5 during pregnancy and lactation causes oxidative stress in the mother, negatively affecting offspring’s the emotional and learning memory abilities.²⁹ The oxidation product malondialdehyde (MDA) and the antioxidant catalase (CAT) activity are important indicators for evaluating oxidative stress processes. PM2.5 exposure has significantly reduced CAT activity and increased MDA levels in the pregnant rat serum dose-dependently. Open field tests and Morris water maze experiments suggest maternal exposure to PM2.5 may increase anxiety and cognitive impairment in offspring mice.³⁰ Hypothesized mechanisms associated with environmental particulate matter and ASD include inflammation and microglia activation.³¹ Our research group has previously reported that PM2.5 can activate the NLRP3 inflammasome in hippocampal microglia and increase interleukin-18 (IL-18) and interleukin-1β (IL-1β) levels in a dose-dependent manner, leading to hippocampal neuronal damage.^32,33

Once PM2.5 enters the brain, it triggers the reactive microglia proliferation, producing inflammatory cytokines, such as interleukin 6 (IL-6) and tumor necrosis factor-α (TNF-α), leading to a cycle of neuroinflammation and oxidative damage and possibly causing brain white matter damage.^34,35 Particularly, exposure to high PM2.5 concentrations during gestation resulted in autism-like behavioral deficits in adult mice, including reduced social interaction and increased repetitive behavior.³⁶ Notably, the autism-like behavioral deficits observed in these animal studies have similar outcomes to those reported in human studies.^30,37 Vitamin B, such as folic acid, vitamin B₁₂, and vitamin B₆, are essential for neuronal function, and their deficiency has been associated with an increased risk of neurodevelopmental disorders.³⁸ Therefore, vitamin B supplementation may attenuate autism-like behavior and neurodevelopmental impairment in the hippocampus of mice exposed to PM2.5 during gestation by suppressing inflammation and oxidative stress, exhibiting a preventive effect.^39,40 However, the potential mechanisms underlying vitamin B’s amelioration of PM2.5-induced neurodevelopmental impairment in offspring during pregnancy require further elucidation. Vitamin B application is also expected to be a promising therapeutic for ASD.

Dysregulation of the PKA/CREB/BDNF signaling pathway

The PKA/CREB/BDNF signaling pathway has recently been implicated in PM2.5-induced neurodevelopmental toxicity. The cAMP-mediated protein kinase A (PKA) activation is essential for cell signaling. The cAMP response element binding protein (CREB) is a target for PKA that can be activated by PKA phosphorylation at serine 133. CREB, an activated transcription factor, regulates the downstream target gene expression, such as brain-derived neurotrophic factor (BDNF), thereby promoting neuronal development, inhibiting neuronal apoptosis, and enhancing synaptic plasticity.^41,42 Synapses provide the structural basis for information transmission between neurons and are essential for cognition and emotion. The synapses formation characterizes the developing brain, and this stage is vulnerable to environmental toxins,⁴³ such as PM2.5, disrupting synaptic structures, reducing hippocampal synaptic-related proteins (PSD95 and SYP) expressions, and impairing emotional and cognitive development, especially when exposed during the early postnatal period.⁴⁴ A recent in vitro study using primary cultured hippocampal neurons as a model reported that exposure to PM2.5 increased neuronal apoptosis in a concentration-dependent manner. When hippocampal neurons cultured for 3 days in vitro (DIV3) were exposed to PM2.5 for 24 h and 96 h, neuronal viability decreased by 18.8% and 32.7% respectively. Transmission electron microscopy revealed damage to synaptic ultrastructure and reduced PKA and CREB phosphorylation and BDNF expression levels at the molecular level.⁴⁵ Our in vitro co-culture model of hippocampal neurons and microglia also exhibited significant reductions in SYP and PSD-95 and p-CREB and BDNF under PM2.5 exposure,³² suggesting that the PKA/CREB/BDNF signaling pathway is involved in PM2.5-induced developmental toxicity in hippocampal neurons. Synaptamide has been discovered to improve synaptic plasticity and cognitive function by specifically activating the PKA/CREB pathway.^46,47 Therefore, targeting the PKA/CREB/BDNF signaling pathway may offer a promising therapeutic strategy for ameliorating PM2.5-induced neurodevelopmental damage.

Gut microbiome dysbiosis

The gut microbiome regulates the host brain and body development and an immune system function throughout early human life and childhood.⁴⁸ ASD symptomatology is also directly linked to the gut microbiome.⁴⁹ Gastrointestinal symptoms are common in autistic children, affecting 46% to 84% of them.⁵⁰ Studies have presented that alterations in the gut microbiota and its metabolites can cause ASD-like behavior in rodent models and ASD symptoms in patients.^51,52 Additionally, a Jinan, China prospective study demonstrated for the first time a link between PM2.5 and the GBA of the microbiota. The study found changes in neurological outcomes by measuring real-time personal PM2.5 in 76 healthy elderly participants and collecting and analyzing fecal and blood samples, e.g. increases of 19.77% (95% CI: -36.44, 125.69) in anxiety were associated with 10 μg/m³ increase in PM2.5 at the lag 0-72 h. PM2.5 exposure can cause neurological dysfunction by affecting the gut microbiota, tryptophan metabolism and activating GBA by inflammatory factors.¹¹ Furthermore, environmental factors during the prenatal and neonatal periods can induce dysbiosis and affect microglial maturation and activation, thereby altering brain function and increasing the risk of ASD.¹² However, further research is necessary to elucidate the specific mechanisms by which PM2.5 and gut microbiota combine to cause ASD, particularly in humans. Figure 2 illustrates the ASD pathogenesis associated with exposure to PM2.5.

Figure 2.

Pathogenesis of ASD associated with exposure to PM2.5. The figure illustrates the potential impacts of PM2.5 on the in vivo development of children with ASD. In the brain, PM2.5 produces neurotoxicity by acting on hippocampal neurons and microglia, resulting in reduced dendritic spine numbers and increased neuronal apoptosis, which is also exacerbated by the release of large amounts of inflammatory factors from over-activated microglia. In the gut, PM2.5-induced dysbiosis of the gut microflora can lead to neurological dysfunction via the gut-brain axis (GBA), and brain damage can also exacerbate the dysfunction of the gut. Figure created using BioRender.com images.

Epigenetics of PM2.5 and ASD

Epigenetic inheritance is a system of molecular markers that allows two individuals with identical gene sequences to exhibit vastly different traits. Epigenetics may be associated with early environmental and genetic influences on neurodevelopmental risk due to air pollution.^53,54 DNA methylation is an important epigenetic marker, and its dysregulation due to genetic or environmental damage can lead to cognitive deficits and behavioral abnormalities.⁵⁵ DNA methylation is altered in the ASD brain, suggesting epigenetic dysregulation is a potential mechanism for ASD pathogenesis.^56,57 Epidemiological studies also provide strong biological evidence for a correlation between abnormal DNA methylation and PM2.5-related health effects, specifically significant genomic hypomethylation in PM2.5-exposed populations.^58,59

Notably, PM2.5 has been shown to interfere with gene-specific DNA methylation and mRNA expression of ASD candidate genes and reduce the synapse-associated gene expression in human neuronal cell models.⁶⁰ Many ASD candidate genes contribute to the synapse structure and function. Dendritic spines are small actin-rich protrusions that form the postsynaptic portion of most excitatory synapses and influence synaptic function and plasticity.⁶¹ Individuals with ASD exhibit abnormalities in the number and shape of dendritic spines, resulting in brain dysfunction. Postsynaptic density proteins (PSDs) include cell adhesion molecules, scaffolding proteins, receptors, and cytoskeletal proteins, which underpin synaptic transmission and plasticity. Thus, alterations in these proteins play an important role in ASD pathogenesis.⁶²

SHANK3 is a highly plausible candidate ASD gene, functioning as a synaptic scaffolding protein predominantly located in the postsynaptic region of excitatory synapses and critical for synapse formation and dendritic spine maturation.⁶³ Evidence from epidemiological and animal studies suggests that SHANK3 hypermutability and hypermethylation are observed in ASD patients and animal models.^64–66 In an in vivo study, neonatal male Sprague-Dawley rats were chosen and exposed to PM2.5 (2 or 20 mg/kg body weight, once a day) by intranasal instillation from postnatal day 8 to 22. It was found that both groups of the exposure rats in the early postnatal period developed an autism-like state, with significantly reduced SHANK3 protein levels in the hippocampus.⁶⁷ This reduction may have been caused by PM2.5-induced up-regulation of DNA methylation levels in the SHANK3 promoter.⁶⁰ A recent study also confirmed the role of SHANK3 in concentrated ambient PM2.5 exposure-induced autism-like phenotype, providing new ideas for the etiology and prevention of autism.⁶⁸

Moreover, studies have identified a significant reduction in Reelin expression in the brains of ASD individuals and a methylation pattern of its promoter.^69–71 Reelin is a signaling glycoprotein secreted in the limbic region of the developing cerebral cortex. It is essential in neuronal migration, dendritic spine formation, synaptogenesis, and synaptic plasticity.⁷² Exposure to diesel exhaust (DE) during mouse development has reduced Reelin expression, disrupting cortical structures and leading to ASD-like behavior.⁷³ However, whether PM2.5 can influence ASD progression by regulating the Reelin gene expression remains unknown, and further investigation is needed.

PM2.5 and neurodegenerative diseases

The World Health Organization (WHO) has predicted that neurodegenerative diseases will be the greatest health problem in the 21st century, with Alzheimer's disease (AD) and Parkinson’s disease (PD) considered the most incurable neurological disorders.⁷⁴ These diseases increase dramatically with age, posing a huge medical and public health burden. Although the etiology of most neurodegenerative diseases is unclear, genetic and environmental factors play a crucial role. Extensive research indicates that PM2.5 is an important environmental risk factor for neurodegenerative diseases.^75,76 This section discusses the relationship between PM2.5 exposure and AD and PD in more detail, as these diseases represent the most common neurodegenerative disorders. Most evidence points to a potential relationship between them and PM2.5.

PM2.5 and AD

PM2.5 as the independent risk factor for AD

AD is a progressive degenerative nervous system disorder with an insidious onset and is the most prevalent form of dementia. AD is pathologically characterized by amyloid plaques and neurofibrillary tangles in the brain, leading to associated loss of synapses and neurons, cognitive deficits, and eventually dementia.⁷⁷ Age is the most important factor influencing AD onset, and as the population ages rapidly, the number of people with AD increases.⁷⁸ However, the exact etiology and pathogenesis of AD are still unknown. Age-associated genetic mutations and air pollution are currently known risk factors for AD development, with PM2.5 being an independent risk factor in developing AD.^76,79

Several studies have assessed the association between PM2.5 exposure and cognitive impairment, an important initial manifestation of AD.^80,81 According to reports, older people living in areas with high PM2.5 concentrations are more prone to cognitive decline.^82,83 A recent study in a French elderly population (≥65 years, 62% of whom were female) reported a correlation between long-term PM2.5 exposure and increased dementia incidence, with PM2.5 concentrations positively associated with the risk.⁷⁹ Another longitudinal study of 2253 residents over 60 years of age in the central Stockholm revealed that annual mean PM2.5 concentrations (8.6 μg/m³) affected the incidence of dementia, suggesting that PM2.5 is an independently important risk factor for it.⁸⁴ However, a New York State study discovered no significant relationship between long-term PM2.5 exposure and hospitalization rates for AD or dementia, possibly due to a bias caused by misclassification of exposure.⁸⁵ Another population-based study in Rotterdam lacked clear evidence of an association between exposure to PM2.5 and the risk of dementia or cognitive decline.⁸⁶ Despite the lack of direct evidence correlating PM2.5 exposure and AD onset, the positive association between PM2.5 and the onset of dementia may serve as indirect evidence of its association with AD. Table 1 summarizes the epidemiological relationship between PM2.5 and AD.

Table 1.

The Epidemiological Relationship Between PM2.5 and AD.

Study Subjects	Follow-up period	Location	PM2.5 concentration	Study design	Findings
7066 participants aged ≥65 years, with a median age of 73.4 years, 62% of whom were female	12 years	French	Range 14.6-31.3 µg/m³	Prospective cohort	PM2.5 concentration was positively associated with dementia risk: HR = 1.20, 95% CI (1.08–1.32) for all-cause dementia, 1.20 (1.09–1.32) for AD per 5 µg/m³ PM2.5 increase.
Approximately 9.8 million Medicare enrollees aged ≥65 living in 50 cities in the northeastern United States	1999-2010	Northeastern United States	Average (AVG) 12.0 μg/m³ (SD = 1.6, IQR = 3.8 μg/m³)	Cohort study	City-wide PM2.5 exposure was associated with accelerated disease progression: HR = 1.15, 95% CI (1.11-1.19) for AD first hospital admissions per 1-μg/m³ increase in annual PM2.5 concentrations.
2253 residents over 60 years of age in the Kungsholmen district of central Stockholm	1990-2011	Stockholm, Sweden	Average (AVG) 8.6 μg/m³	Longitudinal Population-Based Study	Low to mean PM2.5 levels were associated with higher risk of accelerated cognitive decline: an increased OR of fast cognitive decline of 81% (95%CI = 1.2–3.2) per interquartile range difference up to mean PM2.5 level (8.6 μg/m³) for individuals older than 80.
A national sample of non-Hispanic white and black men and women aged 55 and older	1986-2002	USA	Average (AVG) 13.8 μg/m³	Longitudinal Study	Older adults living in areas with high concentrations of PM2.5 had an error rate 1.5 times greater than those exposed to lower concentrations.
1806 participants in an area with the highest quartile of PM2.5 from residential wood burning	1993-2010	Umeå, Northern Sweden	Residential wood burning PM2.5 range 0.21-3.34 μg/m³	Longitudinal Study	PM2.5 from residential wood burning and traffic are associated with the incidence of AD: Participants were more likely to develop AD than those blazing without a wood-burning stove, hazard ratios 1.74 (CI: 1.10-2.75, p-value 0.018).
63,287 inpatients with a primary diagnosis of either AD, dementia, or Parkinson’s disease (PD) living within 15 miles of PM2.5 monitoring sites in six urban areas	2005-2016	New York, USA	Range 8.6-11.9 µg/m³	Longitudinal Study	There was no clear association between overall ambient PM2.5 concentrations or source-assigned ambient PM2.5 contributions and hospital admissions for neurological disorders.

Mechanisms underlying PM2.5-induced AD

Hyperactivation of microglia

Over the past decade, numerous studies have demonstrated that PM2.5 accelerates the effects of AD by inducing neuroinflammatory processes.^87,88 The hallmark of neuroinflammation is immune cell activation, such as microglia and astrocytes.⁸⁹ Notably, microglial activation has been identified as a major factor in AD pathogenesis.^90,91 Emerging evidence suggests that PM2.5 exposure causes neurotoxicity by activating microglia.⁹² Therefore, we hypothesize that PM2.5-induced microglial activation-mediated neuroinflammation plays an important role in AD pathogenesis.

Microglia, the resident macrophages of the CNS, play a crucial role in the brain's immune system. Microglia become activated over a long period during chronic inflammation and subsequently release various inflammatory mediators and neurotoxic substances, such as tumor necrosis factor (TNF), interleukins (IL), and nitric oxide (NO), thereby leading to tau protein deposition and propagation, neuronal loss, and cognitive decline.^90,93 Moreover, studies have discovered that microglia activated under PM2.5 conditions release more pro-inflammatory cytokines, such as TNF-α and IL-1β.⁹⁴ A recent study using mixed glial and neuronal cultures in vitro from the neonatal rat cerebral cortex revealed that microglia-derived TNF-α can mediate PM in air pollution-related neurodegenerative changes, thereby altering synaptic function and neuronal growth.⁹⁵ Another study in an in vitro model of AD demonstrated that PM2.5 exposure exacerbated neuronal damage and inflammation in neuron-microglia co-cultures by increasing IL-1β production.⁹⁶ Therefore, PM2.5 may have deleterious effects on AD by causing neuroinflammation through excessive microglia activation. Consequently, microglia-targeted therapy may provide the key to effective AD therapies.

Epigenetics of PM2.5 and AD

The apolipoprotein E gene (APOE) is the strongest genetic risk factor for AD. Several studies have presented that alterations in APOE low DNA methylation may be an important factor contributing to the strong effects of APOE on AD risk.^97,98 Moreover, the APOE 4 allele may also play a crucial role in the effects of air pollution in some studies.^99,100 A recent study suggests that APOE carriers have a stronger association with PM2.5 and dementia.¹⁰¹ Clinical and epidemiological studies investigating the long-term effects of PM2.5 exposure suggest that PM2.5 may reduce genomic DNA methylation and trigger neuroinflammation.^58,59 Besides nuclear DNA, PM2.5 affects mtDNA methylation, an interesting biomarker for AD.¹⁰² An experimental study has displayed that mtDNA methylation levels in the blood of individuals exposed to PM2.5 were negatively correlated with PM2.5 concentrations.¹⁰³ Thus, the effects of PM2.5 exposure on AD progression may be related to DNA hypomethylation, particularly the hypomethylation levels of APOE4 and mtDNA.

Additionally, non-coding RNAs (ncRNAs) play a crucial role in the pathogenesis of many human diseases, including AD, and numerous AD-related ncRNAs have been identified.^104,105 However, few studies have examined the relationship between PM2.5-induced AD-like changes and ncRNAs. Recent reports suggest that long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) may play an important role in PM2.5-mediated inflammatory responses.¹⁰⁶ In an in vivo study investigating AD-like changes in a mouse model of chronic PM2.5 exposure (50 μg/mL), dysregulation of microglia-associated lncRNAs play a key role in cognitive impairment.¹⁰⁷ Additionally, following system exposure to PM2.5 for 3 months in normal mice and in chronic obstructive pulmonary disease (COPD) model mice, circRNAs, such as circBbs9, can exacerbate the PM2.5-induced cellular inflammatory response by activating the NLRP3 inflammasome when overexpressed.¹⁰⁸ These findings suggest that ncRNAs may be involved in PM2.5-induced cognitive impairment and influence AD progression.

Current animal experiments and epidemiological studies have established a correlation between PM2.5 exposure and AD epigenetics. However, the specific epigenetic mechanisms underlying this relationship must be further explored.

PM2.5 and PD

Association between PM2.5 and the Risk for PD

PD is the second most prevalent neurodegenerative disease after AD. It is characterized by the loss of dopaminergic neurons in the substantia nigra and the formation of Lewy bodies composed of α-synuclein.^109,110 When approximately 80% of dopaminergic neurons are lost, patients may experience clinical symptoms such as motor retardation and non-motor symptoms such as depression and cognitive impairment. Despite being unknown, the exact cause of PD is attributed to several factors, including aging, genetic, and environmental factors that increase the risk of PD.¹¹¹ Air pollution, particularly PM2.5, is a contributing factor to PD development. Several epidemiological studies have investigated the possible association between PM2.5 and PD.

Exposure to air pollutants, particularly PM2.5 (mean annual concentration = 9.8 µg/m³), was related to an increased risk for PD in a population-based cohort study conducted in Ontario, Canada.¹¹² Furthermore, short-term exposure to PM2.5 increased the risk of PD hospitalization in a case-crossover analysis.¹¹³ Two independent studies in New York State have also demonstrated that long-term exposure to PM2.5 may lead to clinical deterioration in PD. The findings support the idea that the adverse effects of PM2.5 on PD may vary depending on particle composition.^76,114 The above epidemiological studies have revealed that short- and long-term exposure to PM2.5 significantly increases the risk for PD. However, a recent meta-analysis reported no statistically significant association between long-term PM2.5 exposure and PD incidence.¹¹⁵ The relationship between PM2.5 exposure and PD development should not be ignored, despite the epidemiological limitations, such as the small number of articles selected and geographical differences in this meta-analysis.

Mechanisms associated with PM2.5-induced PD

Mitochondrial dysfunction

Accumulating evidence suggests that PM2.5-induced mitochondrial dysfunction and oxidative stress may be potential biological mechanisms underlying the deterioration of PD. Previous studies have reported that PM2.5 exposure may induce ultrastructural damage to mitochondria and myelin sheaths, increase apoptosis-related protein expressions, such as Caspase-3 and Caspase-9, and impair neurobehavior.¹¹⁶ Mitochondrial dysfunction has also been associated with PD, leading to oxidative damage and neuronal death.¹¹⁷ Mitochondrial dysfunction promotes reactive oxygen species (ROS) production, causing α-synuclein aggregation or reduced α-synuclein degradation. Increased alpha-synuclein levels lead to mitochondrial damage and dysfunction, creating a positive feedback loop.^118,119 A recent experimental study, using PM2.5 with rotenone treated PC4 cells and C57BL/6 J mice as the in vitro and in vivo models respectively, has revealed that PM2.5 exacerbates PD development both in vitro and in vivo by inducing mitochondrial dysfunction and oxidative stress.¹²⁰ This confirms that mitochondrial dysfunction may play a crucial role in PD development caused by PM2.5.

Systemic inflammation

Systemic inflammation also plays an important role in PD pathogenesis. PM2.5 particles can reach the fine bronchi and alveolar spaces via the nose due to their small size, causing lung and systemic inflammation via the circulatory system.^121,122 Notably, the systemic inflammation observed in PD patients is believed to be conducive to CNS neuroinflammation.¹²³ PM2.5 promotes cytokine secretions, such as TNF-α and IL-1β, in the serum. These inflammatory mediators can enter the brain via the damaged BBB, activating CNS immune cells and causing downstream effects, such as neuronal damage.^124,125 Animal models prove that systemic inflammation promotes neuroinflammation, leading to dopaminergic neuron loss and alpha-synuclein accumulation, particularly the formation of Lewy body-like inclusions.¹²⁶ In conclusion, PM2.5 causes neuroinflammation and induces a systemic inflammatory response that indirectly produces neurotoxicity and increases the risk of PD. Figure 3 presents the pathogenesis and clinical manifestations of PD associated with exposure to PM2.5.

Figure 3.

Pathogenesis and clinical manifestations of PD associated with exposure to PM2.5. PM2.5 can cause systemic inflammation through the circulatory system. Inflammatory mediators released into the blood can cross the BBB into the brain and trigger neuroinflammation, leading to the loss of dopaminergic neurons and the formation of Lewy bodies. Additionally, PM2.5 can stimulate the production of ROS by inducing mitochondrial dysfunction, leading to the accumulation of α-synuclein proteins. This mechanism can create a positive feedback loop between PM2.5-induced ROS and α-synuclein aggregation, exacerbating neuronal damage. Collectively, the pathological changes induced by these mechanisms can contribute to the development of PD and the emergence of relevant clinical symptoms. Figure created using BioRender.com images.

PM2.5 and mental disorders

“An era of mental illnesses is upon us. " The Global Burden of Disease (GBD) 2019 report highlights that mental disorders are among the top 10 leading causes of global burden.¹²⁷ Mental illnesses are a group of neurological disorders that manifest with varying degrees of impairment in cognitive, emotional, volitional, and behavioral mental activities, including schizophrenia, depression, and bipolar disorder, among others.¹²⁸ Biological, psychological, and social-environmental factors cause mental illnesses. New evidence from human and animal studies suggests that sustained exposure to PM2.5, affecting the CNS via various cellular, molecular, inflammatory, and oxidative stress pathways, increases the risk of mental illnesses.^129–131 However, research into the underlying mechanisms remains incomplete. Considering the increasing burden of mental disorders in today's highly polluted world, these findings will increase awareness of vulnerable populations and support the urgent need to reduce exposure to air pollutants.

PM2.5 and schizophrenia

Association between PM2.5 and schizophrenia

Schizophrenia (SZ) is a severe and chronic psychiatric disorder characterized by the dissonance between mental activity and the environment. It typically begins in the middle-aged and young adult stages and is marked by thinking, perception, emotion, and behavior disorders. Although the potential etiology of SZ is unknown, there is agreement that both genetic and environmental factors contribute to somatic vulnerability.^132,133 Urban exposure to environmental toxins and pollutants has been identified as a reliable risk factor for SZ and other psychiatric disorders. Recent evidence indicates that exposure to air pollutants is associated with an increased risk for SZ.^134,135 PM2.5 play a key role in these epidemiological studies on SZ.

The two independent time-series study results have revealed that the risk of hospital admission for SZ patients increases with PM2.5 concentrations.^136,137 Another study in a coastal city in China discovered a positive association between PM2.5 exposure and hospital readmission in SZ patients, with a stronger association in men and young adults (<45 years).¹³⁸ Furthermore, a case report including 1193 patients with SZ stated that ambient PM2.5 concentrations were associated with deterioration in SZ.¹³⁹ In this study, the stratified analysis by age group showed that the ORs associated with PM2.5 concentration increased substantially for patients over 65 years of age, and significant increases were observed at a single lag of 6 days. A prospective study reported a statistically significant correlation between environmental PM2.5 and an increased risk of recurrence in SZ patients.¹⁴⁰ However, despite these findings, a few studies have reported a less consistent association between PM2.5 exposure and SZ risk.^141,142 In contrast, data on the association between the diagnosis or severity of schizophrenia and PM2.5 are insufficient; therefore, we hypothesize a positive association between PM2.5 and schizophrenia.

Mechanisms associated with PM2.5-induced SZ

Oxidative stress

Emerging research suggests that oxidative stress is associated with SZ pathophysiology, and deficiencies in antioxidant capacity increase the risk of SZ.¹⁴³ This prompts us to consider the role of PM2.5-induced increased oxidative stress in the risk of SZ. Total Antioxidant Capacity (T-AOC, also known as TAS) is the total antioxidant level consisting of various antioxidant substances and antioxidant enzymes,¹⁴⁴ which may play a role in this association. People living under conditions with a high concentration of PM2.5 have a 1.85-fold decrease in T-AOC compared to those living under relatively low concentration, reducing the body’s antioxidant capacity.^145,146 A study investigating the correlation between thirty-two DSM-IV SZ paranoid patients and their T-AOC levels also reported a negative correlation between TAS levels and symptom severity in SZ patients.¹⁴⁷ A study employing a mediated effects model indicated that PM2.5 exposure might increase the risk of SZ recurrence and reduce the function of the antioxidant system, particularly T-AOC levels.¹⁴⁸ Thus, oxidative stress may mediate the association between PM2.5 exposure and SZ recurrence, with T-AOC possibly playing a key role.

Neuroinflammation and nasal inflammation

A prospective study conducted in the UK suggests that biological and psychological factors, such as neuroinflammation and social stress, may be relevant mechanisms explaining the increased risk of psychosis due to air pollution.¹⁴⁹ Animal model studies have revealed that PM2.5 exposure increases inflammatory cytokine levels, such as TNF-α and IL-1β, and activates microglia, promoting neuroinflammation.⁸⁸ Additionally, PM2.5 can enter the CNS via the olfactory neuron pathway and induce inflammation in the olfactory neuroepithelium, with brain effects.^150,151 Olfactory disturbances, associated with cognitive abnormalities and negative symptoms in SZ patients, frequently precede neurological and psychiatric manifestations.^152–154 According to a recent inducible olfactory inflammation (IOI) mouse model study, air pollutants, including PM2.5, cause local inflammation in the nasal cavity, affecting brain function and leading to SZ-related neurobehavioral consequences.¹⁵⁵ Therefore, current evidence supports the intriguing hypothesis that PM2.5 may induce SZ via neuroinflammatory mechanisms and nasal inflammation, leading to pathological effects on the CNS.

Dysregulation of the WNT/β-catenin pathway

Dysregulation of the WNT/β-catenin pathway may be associated with neuroinflammation in SZ.^156,157 The WNT/β-catenin signaling pathway is highly conserved and tightly controlled, regulating embryonic development, cell proliferation and differentiation, epithelial-mesenchymal transition (EMT), and metabolic engagement.¹⁵⁸ Down-regulated WNT/β-catenin signaling is necessary and sufficient for microglia activation,¹⁵⁹ and glycogen synthase kinase-3 beta (GSK-3β) is a major inhibitor of this pathway.¹⁶⁰ Several studies have presented dysregulation of WNT/β-catenin pathway-related protein levels in the hippocampus of mouse SZ models, manifesting primarily as decreased β-catenin and increased GSK-3β., WNT gene expression is also impaired in SZ patients.¹⁶¹ Some findings suggest that disrupting the WNT/β-catenin pathway may initiate the neurotoxic process in SZ patients.^162,163 PM2.5 is associated with the WNT/β-catenin pathway activation.^164,165 A study using healthy 7-week-old SPF SD rats and their offspring as an in vivo model showed that early-life exposure to PM2.5 can disrupt the synaptic plasticity and reduce the β-catenin and p-GSK-3β protein levels in the WNT/β-catenin pathway of the hippocampus in offspring rats.¹⁶⁶ These results suggest that PM2.5 may play a pivotal role in the SZ pathophysiology by disrupting the WNT/β-catenin pathway, and GSK-3β may be a potential therapeutic target for SZ.

PM2.5 and mood disorders

Mood disorders are a group of mental illnesses characterized by a simultaneous decline in mood, energy, and motivation, including depression, bipolar disorder, and anxiety spectrum disorders.^167,168 The complex etiology of mood disorders is due to biological, psychological, and social factors. Human and animal investigations suggest that PM2.5 exposure can negatively affect mood and increase the risk of mental disorders.¹⁶⁹ However, the specific mechanisms underlying depression and bipolar disorder involving PM2.5 remain unexplored. Therefore, the following sections focus on the possible contributions of PM2.5 to these two diseases.

PM2.5 and depression

Association between PM2.5 and the Risk of Depression

Depression, also known as the “common cold” of psychiatry, is the most common mental disorder, characterized by core symptoms such as persistent depressed mood and decreased interest. If left untreated, depression can worsen and eventually develop into major depressive disorder. Depression etiology is unknown, but it is widely accepted that biological, psychological, and social environmental factors play a role in its pathogenesis. Genome-wide association studies (GWAS) have revealed a moderate genetic correlation between major depressive disorder and SZ, suggesting a potential common etiology or mechanism between both.¹⁷⁰ In the previous section, we identified a positive association between PM2.5 and SZ, and increasing scientific evidence supports the correlation between PM2.5 and depression.

A study conducted in Northern California examined the association between PM2.5 and symptoms of anxiety and depression in adolescents, demonstrating the role of PM2.5 exposure in enhancing the adverse effects of adolescents’ reactions to social stress.¹⁷¹ Furthermore, long-term exposure to PM2.5 (average concentration = 26.7 μg/m³) affects cognition in adults and increases the risk of major depressive disorder (MDD) in the general population.^172,173 Recent research reported that every 10 μg/m³ increase in PM2.5 increases the risk of MDD by 2.26 times.¹⁷⁴ The data from a case-crossover study also indicated the significant contribution of PM2.5 exposure to the development of hospitalization for depression.¹⁷⁵ However, a systematic evaluation and meta-analysis conducted up to 2019 observed no significant correlation between short-term PM2.5 exposure and depression. Nevertheless, the study has certain limitations, such as high heterogeneity between studies and potential synergistic effects of relevant exposures in multi-pollutant mixtures.¹⁷⁶ Therefore, assuming the limitations of epidemiology, additional in-depth longitudinal studies and investigations into the underlying biological mechanisms are needed to obtain more conclusive results. Table 2 summarizes the epidemiological relationship between PM2.5 and depression.

Table 2.

The Epidemiological Relationship Between PM2.5 and Depression.

Study Subjects	Follow-up period	Location	PM2.5 concentration	Study design	Findings
144 youths from Northern California with an average age of 12.2 years	2013-2017	Northern California, USA	Percentiles range 18-94	Cohort study	Adolescents experiencing anxiety and depression may be particularly vulnerable to the adverse effects of PM2.5 on stress reactivity (p < .001, 95% CI = 0.48 to 1.23).
27,270 participants 15-79 years of age	2002-2010	Seoul, Republic of Korea	Average (AVG) 26.7 μg/m³	Cohort study	Long-term PM2.5 exposure increased the risk of major depressive disorder (MDD) among the general population: The risk of MDD increased with an increase of 10 μg/m³ in PM2.5 in 2007 (HR = 1.44; 95% CI: 1.17, 1.78), PM2.5 between 2007 and 2010 (HR = 1.59; 95% CI: 1.02, 2.49).
598 urban US women receiving antenatal care	2002-2007	USA	Average (AVG) 16.5 μg/m³	Prospective cohort	Increased PM2.5 exposure in mid-pregnancy was associated with increased depressive and anhedonia symptoms, particularly in Black women.
41,844 nurses with an average age of 66.6 years	1996-2008	USA	Average (AVG) 12.6 μg/m³	Prospective cohort	PM2.5 exposure leads to a slightly increased risk of depressive episodes (per 10 -μg/m³ increase in 1-year PM2.5, HR = 1.08; 95% CI: 0.97, 1.20).
334,986 participants aged 40-69 years, with a median age of 56.1 years, 51.5% of whom were female	2006-2010	UK	Quintile 1 (<9.3); Quintile 2 (9.3–9.9); Quintile 3 (9.9–10.6); Quintile 4 (≥10.6)	Cohort study	There is a positive correlation between PM2.5 and mental disorders: The odds for the risk of major depression and bipolar disorder increased by 2.26 and 4.99 times per 10 μg/m³ increase in PM2.5.
80,813 patients admitted to hospital for depression	2009-2013	Taipei, Taiwan, China	Average (AVG) 27.8 μg/m³	Case-crossover study	There is a positive association between short-term ambient exposure to PM2.5 and the risk of increased number of hospital admissions for depression in Taipei city, especially on warm days.

Mechanisms associated with PM2.5-induced depression

Dysregulation of the Nrf2/NLRP3 signaling pathway

Nrf2/NLRP3 signaling pathway, regulating inflammation, may play a critical role in PM2.5-induced depression.¹⁷⁷ PM2.5 exposure can activate Nrf2, an important transcription factor that regulates intracellular defense against oxidative stress, thereby enhancing resistance to oxidative stress.¹⁷⁸ However, Nrf2 deficiency promotes PM2.5-induced inflammatory responses via up-regulation of astrocyte activation and nerve damage.¹⁷⁹ Regarding the interaction between oxidative stress and inflammation, the key pro-inflammatory effects also must be mediated by NLRP3 inflammatory vesicle activation. The NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome is a multimeric protein that mediates caspase-1 activation and secretion of the pro-inflammatory cytokine IL-1β/IL-18 in response to microbial infection and cellular injury.¹⁸⁰ The NLRP3 inflammasome has been reported to be a central mediator of depression induced by the immune inflammatory response.¹⁸¹ PM2.5 induces an inflammatory response via NLRP3 inflammasome pathway activation, which requires Nrf2.^182,183 Therefore, we hypothesize that PM2.5 exposure can mediate inflammation and oxidative stress via the Nrf2/NLRP3 signaling pathway, leading to depression.

Hippocampal inflammation

The mood disorders caused by PM2.5-induced hippocampal inflammation have attracted significant attention. Animal models have demonstrated that PM2.5 exposure up-regulates cytokines, such as IL-1β, IL-6, TNF-α, and chemokines, in the hippocampus.¹⁸⁴ Elevated inflammatory cytokine levels in the hippocampus can lead to estrogen deficiency and depression-like behavior in rodents.¹⁸⁵ Additionally, abnormal feedback mechanisms between mood-sensitive glucocorticoids (GC) and hippocampal glucocorticoid receptors (GR) play an important role.^169,186 The hypothalamic-pituitary-adrenal (HPA) axis is the primary stress response system responsible for regulating GC. A hyperactive HPA axis and hypercortisolism are also important biological features of depression. The GR in the hippocampus inhibits HPA axis activity and subsequent GC production via negative feedback under normal physiological conditions.^187,188 In a study in the mouse model, it was found that PM2.5 exposure reduces the GR expression level in the hippocampus, leading to decreased negative feedback to the HPA axis and increased GC secretion. The human test in this study also showed an increase in plasma cortisol secretion after exposure to severe air pollution. This activates the inflammatory response in the hippocampus and ultimately leads to marked depression-like behavior.¹⁶⁹ Notably, the GC concentrations in the saliva samples of human subjects suffering from depression exhibited the same trend as that observed in animal models, supporting this hypothesis.^189,190

PM2.5 and bipolar disorder

Bipolar disorder (BD) is characterized by alternating episodes of mania or hypomania and depression. BD has a peak onset between 15 and 19 years and is one of the leading causes of disability in young people. The causes of BD are unknown, but genetic, neurobiochemical, and psychosocial factors play a role in its development. BD has a high heritability rate (approximately 70%) and is strongly associated with schizophrenia and depression.^191,192 Meanwhile, the impact of environmental factors on these disorders is receiving widespread attention. Several pieces of evidence now assess the association between air pollution and BD.

A cross-sectional study conducted in Milan, Italy, reported that short-term exposure to air pollution was associated with the severity of manic episodes in hospitalized bipolar disorder patients.¹⁹³ Furthermore, a systematic review and meta-analysis presented a statistically significant correlation between PM2.5 and multiple adverse mental health outcomes, including bipolar disorder.¹⁹⁴ The risk of BD increased 4.99 times 174 for every 10 µg/m³ increase in PM2.5.¹⁷⁴ Despite the positive results of current research on the association between PM2.5 and BD, there is still a scarcity of research, and the understanding of the underlying mechanisms remains incomplete. It is well-known that increasing urban greenery, coverage helps reduce PM2.5 concentrations.¹⁹⁵ Exposure to larger and closer green spaces may decrease the risk for BD.¹⁹⁶ Therefore, a comprehensive understanding of the association between PM2.5 and BD and the relevant intervention strategies should receive more attention.

Conclusions and Future Perspectives

In summary, air pollution is a significant environmental health concern. PM2.5, one of the most critical components of air pollutants, is highly linked with developing CNS disorders. PM2.5 exposure can adversely affect the CNS via several pathways, including the BBB, olfactory system, and GBA. The primary adverse outcomes associated with PM2.5 exposure are ASD, AD, PD, SZ, depression, and BD. However, some studies did not discover a significant association, most epidemiological studies have reported a positive association between PM2.5 exposure and these diseases. Animal and clinical studies have provided new evidence that short- or long-term exposure to PM2.5 may cause neurotoxicity via mechanisms, such as neuroinflammation, oxidative stress, systemic inflammation, and intestinal flora dysbiosis. Promising therapeutic targets for alleviating PM2.5-induced neurological damage include inhibiting microglia overactivation, regulating gut microbiota with antibiotics, and targeting signaling pathways, such as PKA/CREB/BDNF and WNT/β-catenin. Additionally, several studies have observed an association between PM2.5 exposure and epigenetic changes in neuropsychiatric disorders.

In this review, we provide comprehensive information regarding the role of PM2.5 in neurodevelopment and neurological disorders. Through the meticulous collection of extensive epidemiological data and evidence from both in vivo and in vitro studies, we elucidate the associations and potential mechanisms of action linking PM2.5 exposure to a variety of neurological disorders. These elucidated mechanisms, operating at both the cellular and molecular levels, significantly contribute to the existing theory of PM2.5 neurotoxicity, while also highlighting potential targets for future interventions and treatments of PM2.5-mediated diseases. Nonetheless, it is important to acknowledge the limitations of our study and address several crucial issues to further enhance our understanding of the effects of PM2.5 on the brain. For instance, human epidemiological studies possess inherent limitations, such as the identification of critical 'windows of susceptibility' for PM2.5 exposure, gender differences in potential vulnerability, and possible gene-environment interactions. Furthermore, the complexity of environmental PM2.5 underscores the incomplete nature of our current understanding of the underlying mechanisms, necessitating further exploratory research.

Given the increasing burden of CNS diseases in our polluted world, further targeted and effective interventions are needed to mitigate its detrimental effects on human health. For instance, advocating for the promotion of energy-efficient and environmentally friendly lifestyles and consumption patterns can significantly contribute to environmental preservation. Furthermore, optimizing policies aimed at reducing the permissible levels of PM2.5 emissions holds great potential in effectively preventing and controlling PM2.5 pollution. By implementing these measures, we can collectively work towards mitigating the impact of PM2.5 pollution and safeguarding public health.

Footnotes

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Natural Science Foundation of Shandong Province (No.ZR2021MH031) and Weifang Medical University Scientific Research Innovation Program Doctoral foundation (No.2021BKQ)>.

ORCID iD

Li Yu

References

Feng

Gao

Liao

, et al. The health effects of ambient PM2.5 and potential mechanisms. Ecotoxicol Environ Saf 2016; 128: 67–74.

Pun

Kazemiparkouhi

Manjourides

, et al. Long-Term PM2.5 exposure and respiratory, cancer, and cardiovascular mortality in older US Adults. Am J Epidemiol 2017; 186: 961–969.

Lin

Zou

Yang

, et al. A review of recent advances in research on PM2.5 in China. Int J Environ Res Public Health 2018; 15: E438.

Sagai

. Toxic Components of PM2.5 and their toxicity mechanisms-on the toxicity of sulfate and carbon components. Nihon Eiseigaku Zasshi Jpn J Hyg; 74. Epub ahead of print 2019. DOI: 10.1265/jjh.19004.

Chen

Zhao

, et al. Characteristics, sources and health risks of toxic species (PCDD/Fs, PAHs and heavy metals) in PM2.5 during fall and winter in an industrial area. Chemosphere 2020; 238: 124620.

Bongaerts

Lecante

Bové

, et al. Maternal exposure to ambient black carbon particles and their presence in maternal and fetal circulation and organs: an analysis of two independent population-based observational studies. Lancet Planet Health 2022; 6: e804–e811.

Wei

Xin

, et al. Passage of exogeneous fine particles from the lung into the brain in humans and animals. Proc Natl Acad Sci U S A 2022; 119: e2117083119.

Xie

You

Zhi

, et al. The toxicity of ambient fine particulate matter (PM2.5) to vascular endothelial cells. J Appl Toxicol JAT 2021; 41: 713–723.

Ajmani

Suh

Pinto

. Effects of ambient air pollution exposure on olfaction: A Review. Environ Health Perspect 2016; 124: 1683–1693.

10.

Cheng

Saffari

Sioutas

, et al. Nanoscale particulate matter from urban traffic rapidly induces oxidative stress and inflammation in olfactory epithelium with concomitant effects on brain. Environ Health Perspect 2016; 124: 1537–1546.

11.

Fang

Tang

, et al. PM2.5 exposure associated with microbiota gut-brain axis: Multi-omics mechanistic implications from the BAPE study. Innov Camb Mass 2022; 3: 100213.

12.

Davoli-Ferreira

Thomson

McCoy

. Microbiota and Microglia Interactions in ASD. Front Immunol 2021; 12: 676255.

13.

Wang

Wei

Ding

, et al. Predisposition to Alzheimer’s and Age-Related Brain Pathologies by PM2.5 Exposure: Perspective on the Roles of Oxidative Stress and TRPM2 Channel. Front Physiol 2020; 11: 155.

14.

Sahu

Mackos

Floden

, et al. Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice. J Alzheimers Dis JAD 2021; 80: 761–774.

15.

Wei

Liang

Meng

, et al. Redox/methylation mediated abnormal DNA methylation as regulators of ambient fine particulate matter-induced neurodevelopment related impairment in human neuronal cells. Sci Rep 2016; 6: 33402.

16.

Parenti

Rabaneda

Schoen

, et al. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci 2020; 43: 608–621.

17.

Zheng

Wang

, et al. Gestational Exposure to Particulate Matter 2.5 (PM2.5) Leads to spatial memory dysfunction and neurodevelopmental impairment in hippocampus of mice offspring. Front Neurosci 2018; 12: 1000.

18.

Donzelli

Llopis-Gonzalez

Llopis-Morales

, et al. Particulate matter exposure and attention-deficit/hyperactivity disorder in children: a systematic review of epidemiological studies. Int J Environ Res Public Health 2019; 17: E67.

19.

Forns

Sunyer

Garcia-Esteban

, et al. Air pollution exposure during pregnancy and symptoms of attention deficit and hyperactivity disorder in children in Europe. Epidemiol Camb Mass 2018; 29: 618–626.

20.

Masini

Loi

Vega-Benedetti

, et al. An overview of the main genetic, epigenetic and environmental factors involved in autism spectrum disorder focusing on synaptic activity. Int J Mol Sci 2020; 21: E8290.

21.

Eckel

Wang

, et al. Sex-specific associations of autism spectrum disorder with residential air pollution exposure in a large Southern California pregnancy cohort. Environ Pollut Barking Essex 2019; 254: 113010.

22.

Rahman

Shu

Y-H

Chow

, et al. Prenatal exposure to air pollution and autism spectrum disorder: sensitive windows of exposure and sex differences. Environ Health Perspect 2022; 130: 17008.

23.

Rahman

Carter

Lin

, et al. Associations of Autism Spectrum Disorder with PM2.5 Components: a comparative study using two different exposure models. Environ Sci Technol 2023; 57: 405–414.

24.

Ritz

Liew

Yan

, et al. Air pollution and Autism in Denmark. Environ Epidemiol Phila Pa 2018; 2: e028.

25.

McGuinn

Windham

Kalkbrenner

, et al. Early life exposure to air pollution and autism spectrum disorder: findings from a multisite case-control study. Epidemiol Camb Mass 2020; 31: 103–114.

26.

Chen

Jin

, et al. Early life exposure to particulate matter air pollution (PM1, PM2.5 and PM10) and autism in Shanghai, China: A case-control study. Environ Int 2018; 121: 1121–1127.

27.

Dutheil

Comptour

Morlon

, et al. Autism spectrum disorder and air pollution: A systematic review and meta-analysis. Environ Pollut Barking Essex 2021; 278: 116856.

28.

Pagalan

Bickford

Weikum

, et al. Association of prenatal exposure to air pollution with autism spectrum disorder. JAMA Pediatr 2019; 173: 86–92.

29.

Jia

Z-L

Zhu

C-Y

Rajendran

, et al. Impact of airborne total suspended particles (TSP) and fine particulate matter (PM2.5)-induced developmental toxicity in zebrafish (Danio rerio) embryos. J Appl Toxicol JAT 2022; 42: 1585–1602.

30.

Zhang

Liu

Zhou

, et al. Neurodevelopmental toxicity induced by maternal PM2.5 exposure and protective effects of quercetin and Vitamin C. Chemosphere 2018; 213: 182–196.

31.

Nephew

Nemeth

Hudda

, et al. Traffic-related particulate matter affects behavior, inflammation, and neural integrity in a developmental rodent model. Environ Res 2020; 183: 109242.

32.

Liu

She

Huang

, et al. HMGB1-NLRP3-P2X7R pathway participates in PM2.5-induced hippocampal neuron impairment by regulating microglia activation. Ecotoxicol Environ Saf 2022; 239: 113664.

33.

Zhang

Sun

Wang

, et al. Gestational exposure to PM2.5 leads to cognitive dysfunction in mice offspring via promoting HMGB1-NLRP3 axis mediated hippocampal inflammation. Ecotoxicol Environ Saf 2021; 223: 112617.

34.

Allen

Oberdorster

Morris-Schaffer

, et al. Developmental neurotoxicity of inhaled ambient ultrafine particle air pollution: Parallels with neuropathological and behavioral features of autism and other neurodevelopmental disorders. Neurotoxicology 2017; 59: 140–154.

35.

Amor

McNamara

Gerrits

, et al. White matter microglia heterogeneity in the CNS. Acta Neuropathol 2022; 143: 125–141.

36.

Church

Tijerina

Emerson

, et al. Perinatal exposure to concentrated ambient particulates results in autism-like behavioral deficits in adult mice. Neurotoxicology 2018; 65: 231–240.

37.

Sobolewski

Anderson

Conrad

, et al. Developmental exposures to ultrafine particle air pollution reduces early testosterone levels and adult male social novelty preference: Risk for children’s sex-biased neurobehavioral disorders. Neurotoxicology 2018; 68: 203–211.

38.

Kumar

Mahajan

Sapehia

, et al. Effects of altered maternal folate and vitamin B12 on neurobehavioral outcomes in F1 male mice. Brain Res Bull 2019; 153: 93–101.

39.

Wang

Sun

, et al. B-vitamin supplementation ameliorates anxiety- and depression-like behavior induced by gestational urban PM2.5 exposure through suppressing neuroinflammation in mice offspring. Environ Pollut Barking Essex 2020; 266: 115146.

40.

Wang

Zhang

Sun

, et al. Gestational B-vitamin supplementation alleviates PM2.5-induced autism-like behavior and hippocampal neurodevelopmental impairment in mice offspring. Ecotoxicol Environ Saf 2019; 185: 109686.

41.

Bai

Zhao

Liu

, et al. Adiponectin confers neuroprotection against cerebral ischemia-reperfusion injury through activating the cAMP/PKA-CREB-BDNF signaling. Brain Res Bull 2018; 143: 145–154.

42.

Kowiański

Lietzau

Czuba

, et al. BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol 2018; 38: 579–593.

43.

Miguel

Pereira

Silveira

, et al. Early environmental influences on the development of children’s brain structure and function. Dev Med Child Neurol 2019; 61: 1127–1133.

44.

Liu

Yang

, et al. Effects of early postnatal exposure to fine particulate matter on emotional and cognitive development and structural synaptic plasticity in immature and mature rats. Brain Behav 2019; 9: e01453.

45.

Liu

Yuan

, et al. Role of PKA/CREB/BDNF signaling in PM2.5-induced neurodevelopmental damage to the hippocampal neurons of rats. Ecotoxicol Environ Saf 2021; 214: 112005.

46.

Tyrtyshnaia

Bondar

Konovalova

, et al. Synaptamide improves cognitive functions and neuronal plasticity in neuropathic Pain. Int J Mol Sci 2021; 22: 12779.

47.

Kim

H-Y

Spector

N-Docosahexaenoylethanolamine . A neurotrophic and neuroprotective metabolite of docosahexaenoic acid. Mol Aspects Med 2018; 64: 34–44.

48.

Zhuang

Chen

Zhang

, et al. Intestinal microbiota in early life and its implications on childhood health. Dev Reprod Biol 2019; 17: 13–25.

49.

Iglesias-Vázquez

Van Ginkel Riba

Arija

, et al. Composition of gut microbiota in children with autism spectrum disorder: a systematic review and meta-analysis. Nutrients 2020; 12: E792.

50.

Al-Beltagi

. Autism medical comorbidities. World J Clin Pediatr 2021; 10: 15–28.

51.

Kamimura

Kaneko

Morita

, et al. Microbial colonization history modulates anxiety-like and complex social behavior in mice. Neurosci Res 2021; 168: 64–75.

52.

Buffington

Di Prisco

Auchtung

, et al. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 2016; 165: 1762–1775.

53.

Park

Lee

Kim

, et al. The role of histone modifications: from neurodevelopment to neurodiseases. Signal Transduct Target Ther 2022; 7: 217.

54.

Shukla

Bunkar

Kumar

, et al. Air pollution associated epigenetic modifications: Transgenerational inheritance and underlying molecular mechanisms. Sci Total Environ 2019; 656: 760–777.

55.

Poon

Tse

LSR

Lim

. DNA methylation in the pathology of Alzheimer’s disease: from gene to cognition. Ann N Y Acad Sci 2020; 1475: 15–33.

56.

Hannon

Schendel

Ladd-Acosta

, et al. Elevated polygenic burden for autism is associated with differential DNA methylation at birth. Genome Med 2018; 10: 19.

57.

Tremblay

Jiang

Y-H

. DNA Methylation and susceptibility to autism spectrum disorder. Annu Rev Med 2019; 70: 151–166.

58.

Gondalia

Baldassari

Holliday

, et al. Methylome-wide association study provides evidence of particulate matter air pollution-associated DNA methylation. Environ Int 2019; 132: 104723.

59.

de Oliveira

AAF

de Oliveira

Dias

, et al. Genotoxic and epigenotoxic effects in mice exposed to concentrated ambient fine particulate matter (PM2.5) from São Paulo city, Brazil. Part Fibre Toxicol 2018; 15: 40.

60.

Wei

Liang

Meng

61.

Suratkal

Yen

Y-H

Nishiyama

. Imaging dendritic spines: molecular organization and signaling for plasticity. Curr Opin Neurobiol 2021; 67: 66–74.

62.

LH-Y

Lai

K-O

. Dysregulation of protein synthesis and dendritic spine morphogenesis in ASD: studies in human pluripotent stem cells. Mol Autism 2020; 11: 40.

63.

Guo

Chen

, et al. Anterior cingulate cortex dysfunction underlies social deficits in Shank3 mutant mice. Nat Neurosci 2019; 22: 1223–1234.

64.

Liu

C-X

C-Y

C-C

, et al. CRISPR/Cas9-induced shank3b mutant zebrafish display autism-like behaviors. Mol Autism 2018; 9: 23.

65.

Gouder

Vitrac

Goubran-Botros

, et al. Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations. Sci Rep 2019; 9: 94.

66.

Kathuria

Nowosiad

Jagasia

, et al. Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development. Mol Psychiatry 2018; 23: 735–746.

67.

Cui

, et al. Early postnatal exposure to airborne fine particulate matter induces autism-like phenotypes in male rats. Toxicol Sci Off J Soc Toxicol 2018; 162: 189–199.

68.

Liang

Xie

, et al. Role of SHANK3 in concentrated ambient PM2. 5 exposure induced autism-like phenotype. Heliyon 2023; 9: e14328.

69.

Lintas

Sacco

Persico

. Differential methylation at the RELN gene promoter in temporal cortex from autistic and typically developing post-puberal subjects. J Neurodev Disord 2016; 8: 18.

70.

Lammert

Howell

. RELN mutations in autism spectrum disorder. Front Cell Neurosci 2016; 10: 84.

71.

Di Donato

Guerrini

Billington

, et al. Monoallelic and biallelic mutations in RELN underlie a graded series of neurodevelopmental disorders. Brain J Neurol 2022; 145: 3274–3287.

72.

Jossin

. Reelin functions, mechanisms of action and signaling pathways during brain development and maturation. Biomolecules 2020; 10: E964.

73.

Chang

Y-C

Daza

Hevner

, et al. Prenatal and early life diesel exhaust exposure disrupts cortical lamina organization: Evidence for a reelin-related pathogenic pathway induced by interleukin-6. Brain Behav Immun 2019; 78: 105–115.

74.

Moradi

Jalili

Farhadian

, et al. Polyphenols and neurodegenerative diseases: focus on neuronal regeneration. Crit Rev Food Sci Nutr 2022; 62: 3421–3436.

75.

Rhew

Kravchenko

Lyerly

. Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer’s disease, non-Alzheimer’s dementia, and Parkinson’s disease in North Carolina. PLoS One 2021; 16: e0253253.

76.

Nunez

Boehme

Weisskopf

, et al. Fine particle exposure and clinical aggravation in neurodegenerative diseases in New York State. Environ Health Perspect 2021; 129: 27003.

77.

Congdon

Sigurdsson

. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol 2018; 14: 399–415.

78.

■■■ . Alzheimer’s disease facts and figures. Alzheimers Dement J Alzheimers Assoc 2022; 18: 700–789.

79.

Mortamais

Gutierrez

L-A

de Hoogh

, et al. Long-term exposure to ambient air pollution and risk of dementia: Results of the prospective Three-City Study. Environ Int 2021; 148: 106376.

80.

Grande

Ljungman

PLS

, et al. Long-Term Exposure to PM2.5 and cognitive decline: a longitudinal population-based study. J Alzheimers Dis JAD 2021; 80: 591–599.

81.

Duchesne

Gutierrez

L-A

Carrière

, et al. Exposure to ambient air pollution and cognitive decline: Results of the prospective Three-City cohort study. Environ Int 2022; 161: 107118.

82.

Salinas-Rodríguez

Fernández-Niño

Manrique-Espinoza

, et al. Exposure to ambient PM2.5 concentrations and cognitive function among older Mexican adults. Environ Int 2018; 117: 1–9.

83.

Yao

Wang

Xiang

. Association between cognitive function and ambient particulate matters in middle-aged and elderly Chinese adults: Evidence from the China Health and Retirement Longitudinal Study (CHARLS). Sci Total Environ 2022; 828: 154297.

84.

Oudin

Segersson

Adolfsson

, et al. Association between air pollution from residential wood burning and dementia incidence in a longitudinal study in Northern Sweden. PLoS One 2018; 13: e0198283.

85.

van Wijngaarden

Rich

Zhang

, et al. Neurodegenerative hospital admissions and long-term exposure to ambient fine particle air pollution. Ann Epidemiol 2021; 54: 79–86.e4.

86.

de Crom

TOE

Ginos

BNR

Oudin

, et al. Air Pollution and the Risk of Dementia: The Rotterdam Study. J Alzheimers Dis JAD 2023; 91: 603–613.

87.

Kim

R-E

Shin

Han

S-H

, et al. Astaxanthin Suppresses PM2.5-Induced Neuroinflammation by Regulating Akt Phosphorylation in BV-2 Microglial Cells. Int J Mol Sci 2020; 21: E7227.

88.

Kang

Tan

H-Y

Lee

, et al. An air particulate pollutant induces neuroinflammation and neurodegeneration in human brain models. Adv Sci Weinh Baden-Wurtt Ger 2021; 8: e2101251.

89.

Schain

Kreisl

. Neuroinflammation in Neurodegenerative Disorders-a Review. Curr Neurol Neurosci Rep 2017; 17: 25.

90.

Spangenberg

Green

. Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models. Brain Behav Immun 2017; 61: 1–11.

91.

Kaur

Sharma

Deshmukh

. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease. Inflammopharmacology 2019; 27: 663–677.

92.

Chen

Guo

Huang

, et al. Urban airborne PM2.5-activated microglia mediate neurotoxicity through glutaminase-containing extracellular vesicles in olfactory bulb. Environ Pollut Barking Essex 2020; 264: 114716.

93.

Hansen

Hanson

Sheng

. Microglia in Alzheimer’s disease. J Cell Biol 2018; 217: 459–472.

94.

Song

Han

Wang

, et al. Microglial activation and oxidative stress in PM2.5-Induced neurodegenerative disorders. Antioxid Basel Switz 2022; 11: 1482.

95.

Cheng

Davis

Hasheminassab

, et al. Urban traffic-derived nanoparticulate matter reduces neurite outgrowth via TNFα in vitro. J Neuroinflammation 2016; 13: 19.

96.

Wang

B-R

Shi

J-Q

N-N

, et al. PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer’s disease. J Neuroinflammation 2018; 15: 132.

97.

Tulloch

Leong

Thomson

, et al. Glia-specific APOE epigenetic changes in the Alzheimer’s disease brain. Brain Res 2018; 1698: 179–186.

98.

Lee

E-G

Tulloch

Chen

, et al. Redefining transcriptional regulation of the APOE gene and its association with Alzheimer’s disease. PLoS One 2020; 15: e0227667.

99.

Jiang

Zeng

, et al. Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE-/- mice. Toxicol Lett 2018; 290: 123–132.

100.

Calderón-Garcidueñas

de la Monte

. Apolipoprotein E4, Gender, body mass index, inflammation, insulin resistance, and air pollution interactions: recipe for Alzheimer’s Disease Development in Mexico City Young Females. J Alzheimers Dis JAD 2017; 58: 613–630.

101.

Andersson

Sundström

Nordin

, et al. PM2.5 and dementia in a low exposure setting: the influence of odor identification ability and APOE. J Alzheimers Dis JAD. Epub ahead of print 9 February 2023. DOI: 10.3233/JAD-220469.

102.

Nikolac Perkovic

Videtic Paska

Konjevod

, et al. Epigenetics of Alzheimer’s Disease. Biomolecules 2021; 11: 195.

103.

Byun

H-M

Colicino

Trevisi

, et al. Effects of air pollution and blood mitochondrial DNA methylation on markers of heart rate variability. J Am Heart Assoc 2016; 5: e003218.

104.

Idda

Munk

Abdelmohsen

, et al. Noncoding RNAs in Alzheimer’s disease. Wiley Interdiscip Rev RNA; 9. Epub ahead of print March 2018. DOI: 10.1002/wrna.1463.

105.

Zhang

Zhao

, et al. The Role of Non-coding RNAs in Alzheimer’s disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers. Front Aging Neurosci 2021; 13: 654978.

106.

Zhong

Wang

Zhang

, et al. Identification of long non-coding RNA and circular RNA in mice after intra-tracheal instillation with fine particulate matter. Chemosphere 2019; 235: 519–526.

107.

Zhang

Wang

, et al. Differential expression of long non-coding RNAs in the hippocampus of mice exposed to PM2.5 in Dalian, China. Environ Sci Pollut Res Int 2022; 29: 12136–12146.

108.

Hua

Shao

, et al. Circular RNA circBbs9 promotes PM2.5-induced lung inflammation in mice via NLRP3 inflammasome activation. Environ Int 2020; 143: 105976.

109.

De Virgilio

Greco

Fabbrini

, et al. Parkinson’s disease: Autoimmunity and neuroinflammation. Autoimmun Rev 2016; 15: 1005–1011.

110.

Tolosa

Garrido

Scholz

, et al. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 2021; 20: 385–397.

111.

Tysnes

O-B

Storstein

. Epidemiology of Parkinson’s disease. J Neural Transm Vienna Austria 2017; 124: 901–905.

112.

Shin

Burnett

Kwong

, et al. Effects of ambient air pollution on incident Parkinson’s disease in Ontario, 2001 to 2013: a population-based cohort study. Int J Epidemiol 2018; 47: 2038–2048.

113.

Wei

Wang

, et al. Short term exposure to fine particulate matter and hospital admission risks and costs in the Medicare population: time stratified, case crossover study. BMJ 2019; 367: l6258.

114.

Nunez

Boehme

, et al. Parkinson’s disease aggravation in association with fine particle components in New York State. Environ Res 2021; 201: 111554.

115.

Wang

Liu

Yan

. Effect of long-term particulate matter exposure on Parkinson’s risk. Environ Geochem Health 2020; 42: 2265–2275.

116.

Zhang

, et al. PM2.5 impairs neurobehavior by oxidative stress and myelin sheaths injury of brain in the rat. Environ Pollut Barking Essex 2018; 242: 994–1001.

117.

Bose

Beal

. Mitochondrial dysfunction in Parkinson’s disease. J Neurochem 2016; 139(Suppl 1): 216–231.

118.

Musgrove

Helwig

Bae

E-J

, et al. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer. J Clin Invest 2019; 129: 3738–3753.

119.

Di Maio

Barrett

Hoffman

, et al. α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease. Sci Transl Med 2016; 8: 342ra78.

120.

Wang

Zhang

, et al. Exposure to PM2.5 aggravates Parkinson’s disease via inhibition of autophagy and mitophagy pathway. Toxicology 2021; 456: 152770.

121.

Ran

Zhou

, et al. Subchronic exposure to concentrated ambient PM2.5 perturbs gut and lung microbiota as well as metabolic profiles in mice. Environ Pollut Barking Essex 2021; 272: 115987.

122.

Sun

Shi

, et al. Short-term PM2.5 exposure induces sustained pulmonary fibrosis development during post-exposure period in rats. J Hazard Mater 2020; 385: 121566.

123.

Williams-Gray

Wijeyekoon

Yarnall

, et al. Serum immune markers and disease progression in an incident Parkinson’s disease cohort (ICICLE-PD). Mov Disord Off J Mov Disord Soc 2016; 31: 995–1003.

124.

Kempuraj

Thangavel

Selvakumar

, et al. Brain and peripheral atypical inflammatory mediators potentiate Neuroinflammation and Neurodegeneration. Front Cell Neurosci 2017; 11: 216.

125.

Chen

, et al. Synergistic effects of particulate matter (PM2.5) and sulfur dioxide (SO2) on neurodegeneration via the microRNA-mediated regulation of tau phosphorylation. Toxicol Res 2017; 6: 7–16.

126.

George

Rey

Tyson

, et al. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease. Mol Neurodegener 2019; 14: 34.

127.

GBD 2019 Mental Disorders Collaborators . Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatr 2022; 9: 137–150.

128.

Manger

. Lifestyle interventions for mental health. Aust J Gen Pract 2019; 48: 670–673.

129.

Bernardini

Trezzi

Quartesan

, et al. Air pollutants and daily hospital admissions for psychiatric care: a review. Psychiatr Serv Wash DC 2020; 71: 1270–1276.

130.

Bauer

Teixeira

. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci 2019; 1437: 57–67.

131.

Qiu

Danesh-Yazdi

Wei

, et al. Associations of short-term exposure to air pollution and increased ambient temperature with psychiatric hospital admissions in older adults in the USA: a case-crossover study. Lancet Planet Health 2022; 6: e331–e341.

132.

Owen

Sawa

Mortensen

. Schizophrenia. Lancet Lond Engl 2016; 388: 86–97.

133.

Marder

Cannon

. Schizophrenia. N Engl J Med 2019; 381: 1753–1761.

134.

Engemann

Svenning

J-C

Arge

, et al. Natural surroundings in childhood are associated with lower schizophrenia rates. Schizophr Res 2020; 216: 488–495.

135.

Attademo

Bernardini

. Air pollution as risk factor for mental disorders: in search for a possible link with Alzheimer’s Disease and Schizophrenia. J Alzheimers Dis JAD 2020; 76: 825–830.

136.

Duan

Luo

Chu

, et al. Time series analysis on the effect of ambient fine particulate matters and temperature interactions on schizophrenia admission in Tongling City of Anhui Province, 2014-2017. Zhonghua Yufang Yixue Zazhi 2019; 53: 51–56.

137.

Bai

Yang

Zhang

, et al. Durational effect of particulate matter air pollution wave on hospital admissions for schizophrenia. Environ Res 2020; 187: 109571.

138.

Liu

Song

, et al. Particulate matter pollution associated with schizophrenia hospital re-admissions: a time-series study in a coastal Chinese city. Environ Sci Pollut Res Int 2021; 28: 58355–58363.

139.

Eguchi

Onozuka

Ikeda

, et al. The relationship between fine particulate matter (PM2.5) and schizophrenia severity. Int Arch Occup Environ Health 2018; 91: 613–622.

140.

Gao

Wei

Pan

, et al. Elevated environmental PM2.5 increases risk of schizophrenia relapse: Mediation of inflammatory cytokines. Sci Total Environ 2021; 753: 142008.

141.

Antonsen

Mok

PLH

Webb

, et al. Exposure to air pollution during childhood and risk of developing schizophrenia: a national cohort study. Lancet Planet Health 2020; 4: e64–e73.

142.

Zhang

Qian

, et al. Short-term effects of air pollution on cause-specific mental disorders in three subtropical Chinese cities. Environ Res 2020; 191: 110214.

143.

Solberg

Refsum

Andreassen

, et al. A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia. Acta Neuropsychiatr 2019; 31: 202–212.

144.

Pedone

Moglianetti

Lettieri

, et al. Platinum nanozyme-enabled colorimetric determination of total antioxidant level in Saliva. Anal Chem 2020; 92: 8660–8664.

145.

Jiang

Gong

, et al. Traffic-related air pollution is associated with cardio-metabolic biomarkers in general residents. Int Arch Occup Environ Health 2016; 89: 911–921.

146.

Zhang

Wang

Gong

, et al. Ambient PM2.5 exposures and systemic biomarkers of lipid peroxidation and total antioxidant capacity in early pregnancy. Environ Pollut Barking Essex 2020; 266: 115301.

147.

Morera-Fumero

Díaz-Mesa

Abreu-Gonzalez

, et al. A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia. PLoS One 2017; 12: e0189348.

148.

Wei

Gao

, et al. Oxidative stress-mediated particulate matter affects the risk of relapse in schizophrenia patients: Air purification intervention-based panel study. Environ Pollut Barking Essex 2022; 292: 118348.

149.

Newbury

Arseneault

Beevers

, et al. Association of air pollution exposure with psychotic experiences during adolescence. JAMA Psychiatr 2019; 76: 614–623.

150.

Wang

, et al. The impact of air pollution on neurodegenerative diseases. Ther Drug Monit 2021; 43: 69–78.

151.

Cheng

Saffari

Sioutas

152.

Kamath

Lasutschinkow

Ishizuka

, et al. Olfactory functioning in first-episode psychosis. Schizophr Bull 2018; 44: 672–680.

153.

Hasegawa

Sawa

, et al.

Olfactory impairment in psychiatric disorders: Does nasal inflammation impact disease psychophysiology?

Transl Psychiatry 2022; 12: 314.

154.

de Nijs

Meijer

de Haan

, et al. Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls. Psychiatry Res 2018; 266: 147–151.

155.

Hasegawa

Namkung

Smith

, et al. Causal impact of local inflammation in the nasal cavity on higher brain function and cognition. Neurosci Res 2021; 172: 110–115.

156.

Jridi

Canté-Barrett

Pike-Overzet

, et al.

Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?

Front Cell Dev Biol 2020; 8: 615131.

157.

Hoseth

Krull

Dieset

, et al. Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder. Transl Psychiatry 2018; 8: 55.

158.

Tang

. WNT/β-catenin signaling in the development of liver cancers. Biomed Pharmacother Biomedecine Pharmacother 2020; 132: 110851.

159.

Van Steenwinckel

Schang

A-L

Krishnan

, et al. Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brain. Brain J Neurol 2019; 142: 3806–3833.

160.

Lin

Song

, et al. GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer. Biochim Biophys Acta Mol Cell Res 2020; 1867: 118659.

161.

Hoseth

Krull

Dieset

, et al. Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder. Transl Psychiatry 2018; 8: 55.

162.

Al-Dujaili

Mousa

Al-Hakeim

, et al. High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments. Schizophr Bull 2021; 47: 530–541.

163.

Vallée

. Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway. Int J Mol Sci 2022; 23: 2810.

164.

Yan

Jin

Lin

, et al. PM2.5 collecting in a tire manufacturing plant affects epithelial differentiation of human umbilical cord derived mesenchymal stem cells by Wnt/β-catenin pathway. Chemosphere 2020; 244: 125441.

165.

Ding

Deng

. PM2.5, Fine particulate matter: a novel player in the epithelial-mesenchymal transition? Front Physiol 2019; 10: 1404.

166.

Zhou

Liu

, et al. [Effects of PM_(2. 5) exposure on synaptic plasticity and Wnt/β-catenin pathway in rat hippocampus]. Wei Sheng Yan Jiu 2020; 49: 473–479.

167.

Datta

Suryadevara

Cheong

. Mood Disorders. Contin Minneap Minn 2021; 27: 1712–1737.

168.

Rakofsky

Rapaport

. Mood Disorders. Contin Minneap Minn 2018; 24: 804–827.

169.

Jia

Wei

, et al. Exposure to Ambient Air Particles Increases the Risk of Mental Disorder: Findings from a Natural Experiment in Beijing. Int J Environ Res Public Health 2018; 15: E160.

170.

Zhao

Nyholt

. Gene-based analyses reveal novel genetic overlap and allelic heterogeneity across five major psychiatric disorders. Hum Genet 2017; 136: 263–274.

171.

Miller

Gillette

Manczak

, et al. Fine particle air pollution and physiological reactivity to social stress in adolescence: the moderating role of anxiety and depression. Psychosom Med 2019; 81: 641–648.

172.

Kim

K-N

Lim

Y-H

Bae

, et al. Long-Term fine particulate matter exposure and major depressive disorder in a community-based urban cohort. Environ Health Perspect 2016; 124: 1547–1553.

173.

Sram

Veleminsky

, et al. The impact of air pollution to central nervous system in children and adults. Neuroendocrinol Lett 2017; 38: 389–396.

174.

Hao

Zuo

Xiong

, et al. Associations of PM2.5 and road traffic noise with mental health: Evidence from UK Biobank. Environ Res 2022; 207: 112221.

175.

Tsai

S-S

Chiu

Y-W

Weng

Y-H

, et al. Relationship between fine particulate air pollution and hospital admissions for depression: a case-crossover study in Taipei. J Toxicol Environ Health A 2021; 84: 702–709.

176.

Fan

S-J

Heinrich

Bloom

, et al. Ambient air pollution and depression: A systematic review with meta-analysis up to 2019. Sci Total Environ 2020; 701: 134721.

177.

Chu

Zhang

Cui

, et al. Ambient PM2.5 caused depressive-like responses through Nrf2/NLRP3 signaling pathway modulating inflammation. J Hazard Mater 2019; 369: 180–190.

178.

Zhang

, et al. Airborne PM2.5-Induced Hepatic Insulin Resistance by Nrf2/JNK-Mediated Signaling Pathway. Int J Environ Res Public Health 2017; 14: E787.

179.

M-X

Zhu

Y-F

Chang

H-F

, et al. Nanoceria restrains PM2.5-induced metabolic disorder and hypothalamus inflammation by inhibition of astrocytes activation related NF-κB pathway in Nrf2 deficient mice. Free Radic Biol Med 2016; 99: 259–272.

180.

Kelley

Jeltema

Duan

, et al. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int J Mol Sci 2019; 20: E3328.

181.

Kouba

Gil-Mohapel

Rodrigues

SAL

. NLRP3 Inflammasome: From pathophysiology to therapeutic target in major depressive disorder. Int J Mol Sci 2022; 24: 133.

182.

Jia

Liu

Guo

, et al. PM2.5-induced pulmonary inflammation via activating of the NLRP3/caspase-1 signaling pathway. Environ Toxicol 2021; 36: 298–307.

183.

Liu

Zhang

Ding

, et al. Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming. Antioxid Redox Signal 2017; 26: 28–43.

184.

Zheng

Wang

, et al. Gestational Exposure to Particulate Matter 2.5 (PM2.5) Leads to spatial memory dysfunction and neurodevelopmental impairment in hippocampus of mice Offspring. Front Neurosci 2018; 12: 1000.

185.

Sheng

Bao

, et al. NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. Brain Behav Immun 2016; 56: 175–186.

186.

Leistner

Menke

. How to measure glucocorticoid receptor’s sensitivity in patients with stress-related psychiatric disorders. Psychoneuroendocrinology 2018; 91: 235–260.

187.

Cheiran Pereira

Piton

Moreira Dos Santos

, et al. Microglia and HPA axis in depression: An overview of participation and relationship. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry 2021: 1–18.

188.

Juruena

Bocharova

Agustini

, et al. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review. J Affect Disord 2018; 233: 45–67.

189.

Fischer

Strawbridge

Vives

, et al. Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis. Br J Psychiatry J Ment Sci 2017; 210: 105–109.

190.

Beddig

Timm

Ubl-Rachota

, et al. Mindfulness-based focused attention training versus progressive muscle relaxation in remitted depressed patients: Effects on salivary cortisol and associations with subjective improvements in daily life. Psychoneuroendocrinology 2020; 113: 104555.

191.

McIntyre

Berk

Brietzke

, et al. Bipolar disorders. Lancet Lond Engl 2020; 396: 1841–1856.

192.

Vieta

Berk

Schulze

, et al. Bipolar disorders. Nat Rev Dis Primer 2018; 4: 18008.

193.

Carugno

Palpella

Ceresa

, et al. Short-term air pollution exposure is associated with lower severity and mixed features of manic episodes in hospitalized bipolar patients: A cross-sectional study in Milan, Italy. Environ Res 2021; 196: 110943.

194.

Braithwaite

Zhang

Kirkbride

, et al. Air Pollution (Particulate Matter) Exposure and associations with depression, anxiety, bipolar, psychosis and suicide risk: a systematic review and Meta-Analysis. Environ Health Perspect 2019; 127: 126002.

195.

Qiu

Liu

Zhang

, et al. Difference of airborne particulate matter concentration in urban space with different green coverage rates in Baoji, China. Int J Environ Res Public Health 2019; 16: E1465.

196.

Chang

H-T

C-D

Wang

J-D

, et al. Residential green space structures are associated with a lower risk of bipolar disorder: A nationwide population-based study in Taiwan. Environ Pollut Barking Essex 2021; 283: 115864.

Neurodevelopmental toxicity induced by PM2.5 Exposure and its possible role in Neurodegenerative and mental disorders

Abstract

Keywords

Introduction

PM2.5 and neurodevelopmental disorders (NDDs)

Association between PM2.5 and the risk of ASD

Mechanisms associated with PM2.5-induced ASD

Oxidative stress and neuroinflammation

Dysregulation of the PKA/CREB/BDNF signaling pathway

Gut microbiome dysbiosis

Epigenetics of PM2.5 and ASD

PM2.5 and neurodegenerative diseases

PM2.5 and AD

PM2.5 as the independent risk factor for AD

Mechanisms underlying PM2.5-induced AD

Hyperactivation of microglia

Epigenetics of PM2.5 and AD

PM2.5 and PD

Association between PM2.5 and the Risk for PD

Mechanisms associated with PM2.5-induced PD

Mitochondrial dysfunction

Systemic inflammation

PM2.5 and mental disorders

PM2.5 and schizophrenia

Association between PM2.5 and schizophrenia

Mechanisms associated with PM2.5-induced SZ

Oxidative stress

Neuroinflammation and nasal inflammation

Dysregulation of the WNT/β-catenin pathway

PM2.5 and mood disorders

PM2.5 and depression

Association between PM2.5 and the Risk of Depression

Mechanisms associated with PM2.5-induced depression

Dysregulation of the Nrf2/NLRP3 signaling pathway

Hippocampal inflammation

PM2.5 and bipolar disorder

Conclusions and Future Perspectives

Footnotes

Declaration of conflicting interests

Funding

ORCID iD

References